IRIS Accounts Production v23.4.0.336 07908547 director 1.2.23 31.1.24 31.1.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079085472023-01-31079085472024-01-31079085472023-02-012024-01-31079085472022-01-31079085472022-02-012023-01-31079085472023-01-3107908547ns15:EnglandWales2023-02-012024-01-3107908547ns14:PoundSterling2023-02-012024-01-3107908547ns10:Director12023-02-012024-01-3107908547ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3107908547ns10:Micro-entities2023-02-012024-01-3107908547ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3107908547ns10:FullAccounts2023-02-012024-01-3107908547ns10:RegisteredOffice2023-02-012024-01-3107908547ns5:CurrentFinancialInstruments2024-01-3107908547ns5:CurrentFinancialInstruments2023-01-31079085471ns10:Director12023-01-31079085471ns10:Director12022-01-31079085471ns10:Director12023-02-012024-01-31079085471ns10:Director12022-02-012023-01-31079085471ns10:Director12024-01-31079085471ns10:Director12023-01-31
REGISTERED NUMBER: 07908547 (England and Wales)















UNAUDITED CESSATION FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 JANUARY 2024

FOR

PHARMBIZ CONSULTANCY UK LTD

PHARMBIZ CONSULTANCY UK LTD (BY SHARES) (REGISTERED NUMBER: 07908547)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024










Page

Company Information 1

Balance Sheet 2


PHARMBIZ CONSULTANCY UK LTD (BY SHARES)

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2024







DIRECTOR: Ms A Siddiqui





REGISTERED OFFICE: 9 Priors Way
Maidenhead
Berkshire
SL6 2EL





REGISTERED NUMBER: 07908547 (England and Wales)





ACCOUNTANTS: JSA Services Limited
4th Floor
Radius House
51 Clarendon Road
Watford
Hertfordshire
WD17 1HP

PHARMBIZ CONSULTANCY UK LTD (BY SHARES) (REGISTERED NUMBER: 07908547)

BALANCE SHEET
31 JANUARY 2024

2024 2023
£ £
CURRENT ASSETS 67,884 86,224

CREDITORS
Amounts falling due within one year (632 ) (17,382 )
NET CURRENT ASSETS 67,252 68,842
TOTAL ASSETS LESS CURRENT
LIABILITIES

67,252

68,842

CAPITAL AND RESERVES 67,252 68,842

NOTES TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2023 - 1 ) .

2. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2024 and 31 January 2023:

2024 2023
£ £
Ms A Siddiqui
Balance outstanding at start of year (17,292 ) (17,171 )
Amounts advanced 17,292 -
Amounts repaid (332 ) (121 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (332 ) (17,292 )



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PHARMBIZ CONSULTANCY UK LTD (BY SHARES) (REGISTERED NUMBER: 07908547)

BALANCE SHEET - continued
31 JANUARY 2024


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 22 February 2024 and were signed by:





Ms A Siddiqui - Director